Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherShort Communication

THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL

Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
Drug Metabolism and Disposition November 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
Bonnie Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa I. Sanchez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald B. Franklin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Evans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Su-Er W. Huskey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 11 1209-1212
DOI 
https://doi.org/10.1124/dmd.104.000182
PubMed 
15304426

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 9, 2004
  • Accepted August 9, 2004
  • Published online October 13, 2004.

Article Versions

  • Earlier version (August 10, 2004 - 07:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Bonnie Wang,
  2. Rosa I. Sanchez,
  3. Ronald B. Franklin,
  4. David C. Evans and
  5. Su-Er W. Huskey
  1. Department of Drug Metabolism, Merck Research Laboratories, Rahway, New Jersey
  1. Address correspondence to:
    Ms. Bonnie Wang, Dept. of Pharmaceutical Candidate Optimization, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08540. E-mail: bonnie.wang{at}bms.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20172388
Sep 201715717
Oct 201764933
Nov 201739013
Dec 201706720
Jan 201877114
Feb 201895930
Mar 201838518
Apr 201875817
May 201816017
Jun 201884213
Jul 201824920
Aug 201824517
Sep 201806425
Oct 201818526
Nov 201805721
Dec 201843227
Jan 201949712
Feb 201946512
Mar 20195265
Apr 201957910
May 201923814
Jun 20192005
Jul 201930114
Aug 20192646
Oct 20194335
Nov 20195866
Dec 20192042
Jan 20205652
Feb 202086139
Mar 20202772
May 20205331
Jun 20202731
Jul 20204723
Aug 20202525
Sep 20203597
Oct 20204030
Nov 20202321
Dec 20204252
Jan 20212764
Feb 202141101
Mar 20215489
Apr 20212520
May 20212762
Jun 20213121
Jul 20211422
Aug 20211885
Sep 20214554
Oct 20214821
Nov 20213533
Dec 202167103
Jan 20223010
Feb 20223732
Mar 20223164
Apr 20227962
May 20223040
Jun 20223131
Jul 20223331
Aug 20222932
Sep 20225651
Oct 2022190133
Nov 20225731
Dec 20222921
Jan 20236253
Feb 20232841
Mar 20233330

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (11)
Drug Metabolism and Disposition
Vol. 32, Issue 11
1 Nov 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherShort Communication

THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL

Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
Drug Metabolism and Disposition November 1, 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherShort Communication

THE INVOLVEMENT OF CYP3A4 AND CYP2C9 IN THE METABOLISM OF 17α-ETHINYLESTRADIOL

Bonnie Wang, Rosa I. Sanchez, Ronald B. Franklin, David C. Evans and Su-Er W. Huskey
Drug Metabolism and Disposition November 1, 2004, 32 (11) 1209-1212; DOI: https://doi.org/10.1124/dmd.104.000182
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics